Alan T. Monroe

860 total citations
23 papers, 615 citations indexed

About

Alan T. Monroe is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Otorhinolaryngology. According to data from OpenAlex, Alan T. Monroe has authored 23 papers receiving a total of 615 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 9 papers in Surgery and 6 papers in Otorhinolaryngology. Recurrent topics in Alan T. Monroe's work include Head and Neck Surgical Oncology (6 papers), Head and Neck Cancer Studies (6 papers) and Ocular Oncology and Treatments (4 papers). Alan T. Monroe is often cited by papers focused on Head and Neck Surgical Oncology (6 papers), Head and Neck Cancer Studies (6 papers) and Ocular Oncology and Treatments (4 papers). Alan T. Monroe collaborates with scholars based in United States. Alan T. Monroe's co-authors include Christopher G. Morris, William M. Mendenhall, Steven J. Feigenberg, Nancy P. Mendenhall, Niranjan Bhandare, Anuj V. Peddada, Robert J. Amdur, Russell W. Hinerman, M. Tariq Bhatti and Rajat Walia and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and CHEST Journal.

In The Last Decade

Alan T. Monroe

23 papers receiving 599 citations

Peers

Alan T. Monroe
Gamal El-Husseiny Saudi Arabia
Jacqueline A. Wieneke United States
Verity Ahern Australia
W.M. Molenaar Netherlands
Smitha Gollamudi United States
Seung S. Hahn United States
Gamal El-Husseiny Saudi Arabia
Alan T. Monroe
Citations per year, relative to Alan T. Monroe Alan T. Monroe (= 1×) peers Gamal El-Husseiny

Countries citing papers authored by Alan T. Monroe

Since Specialization
Citations

This map shows the geographic impact of Alan T. Monroe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan T. Monroe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan T. Monroe more than expected).

Fields of papers citing papers by Alan T. Monroe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan T. Monroe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan T. Monroe. The network helps show where Alan T. Monroe may publish in the future.

Co-authorship network of co-authors of Alan T. Monroe

This figure shows the co-authorship network connecting the top 25 collaborators of Alan T. Monroe. A scholar is included among the top collaborators of Alan T. Monroe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan T. Monroe. Alan T. Monroe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Peddada, Anuj V., et al.. (2019). Nephron-Sparing Robotic Radiosurgical Therapy for Primary Renal Cell Carcinoma: Single-Institution Experience and Review of the Literature. Advances in Radiation Oncology. 5(2). 204–211. 11 indexed citations
2.
Chera, Bhisham, Kyle Wang, Alan T. Monroe, et al.. (2016). Truth or myth: Definitive chemoradiotherapy doesn’t work for HPV/p16 negative oropharyngeal squamous cell carcinoma?. Oral Oncology. 65. 125–126. 2 indexed citations
3.
Monroe, Alan T., et al.. (2016). Prospectively-collected, tooth-specific dosimetry correlated with adverse dental outcomes. Oral Surgery Oral Medicine Oral Pathology and Oral Radiology. 122(2). 158–163. 11 indexed citations
4.
Peddada, Anuj V., et al.. (2014). Prevention of needle displacement in multifraction high-dose-rate prostate brachytherapy: A prospective volumetric analysis and technical considerations. Practical Radiation Oncology. 5(4). 228–237. 2 indexed citations
5.
Hoppe, Bradford S., et al.. (2013). Postoperative Proton Therapy in the Management of Stage III Thymoma. Journal of Thoracic Oncology. 8(5). e38–e40. 13 indexed citations
6.
Monroe, Alan T., et al.. (2013). Dorsal vagal complex of the brainstem: Conformal avoidance to reduce nausea. Practical Radiation Oncology. 4(4). 267–271. 6 indexed citations
7.
Chera, Bhishamjit S., Bahjat F. Qaqish, Mark C. Weissler, et al.. (2013). Phase II study of de-intensification of radiation and chemotherapy for low-risk HPV-related oropharyngeal squamous cell carcinoma.. Journal of Clinical Oncology. 31(15_suppl). TPS6097–TPS6097. 1 indexed citations
8.
Monroe, Alan T., Dirk Pikaart, & Anuj V. Peddada. (2012). Clinical outcomes of image guided radiation therapy (IGRT) with gold fiducial vaginal cuff markers for high-risk endometrial cancer. Acta Oncologica. 52(5). 1010–1016. 9 indexed citations
9.
Peddada, Anuj V., et al.. (2011). CyberKnife radiosurgery for trigeminal neuralgia: unanticipated iatrogenic effect following successful treatment. Journal of neurosurgery. 115(5). 940–944. 4 indexed citations
11.
Monroe, Alan T., et al.. (2008). Factors associated with radiation-induced nausea and vomiting in head and neck cancer patients treated with intensity modulated radiation therapy. Radiotherapy and Oncology. 87(2). 188–194. 26 indexed citations
12.
Monroe, Alan T., et al.. (2008). High-dose-rate brachytherapy for large prostate volumes (≥50 cc)—Uncompromised dosimetric coverage and acceptable toxicity. Brachytherapy. 7(1). 7–11. 18 indexed citations
13.
Peddada, Anuj V., et al.. (2007). Low Morbidity Following High Dose Rate Brachytherapy in the Setting of Prior Transurethral Prostate Resection. The Journal of Urology. 178(5). 1963–1967. 15 indexed citations
14.
Monroe, Alan T., Niranjan Bhandare, Christopher G. Morris, & William M. Mendenhall. (2005). Preventing radiation retinopathy with hyperfractionation. International Journal of Radiation Oncology*Biology*Physics. 61(3). 856–864. 85 indexed citations
15.
Bhandare, Niranjan, Alan T. Monroe, Christopher G. Morris, M. Tariq Bhatti, & William M. Mendenhall. (2005). Does altered fractionation influence the risk of radiation-induced optic neuropathy?. International Journal of Radiation Oncology*Biology*Physics. 62(4). 1070–1077. 87 indexed citations
16.
Monroe, Alan T., Rajat Walia, Robert A. Zlotecki, & Michael A. Jantz. (2004). Tracheobronchial Amyloidosis. CHEST Journal. 125(2). 784–789. 58 indexed citations
17.
Monroe, Alan T., Niranjan Bhandare, C.G. Morris, & William M. Mendenhall. (2004). Preventing radiation retinopathy with hyperfractionation. International Journal of Radiation Oncology*Biology*Physics. 60(1). S188–S188. 1 indexed citations
18.
Monroe, Alan T., Niranjan Bhandare, C. D. Morris, & William M. Mendenhall. (2004). Preventing radiation retinopathy with hyperfractionation. International Journal of Radiation Oncology*Biology*Physics. 60. S188–S188. 4 indexed citations
19.
Monroe, Alan T., Steven J. Feigenberg, & Nancy P. Mendenhall. (2003). Angiosarcoma after breast‐conserving therapy. Cancer. 97(8). 1832–1840. 158 indexed citations
20.
Monroe, Alan T., Russell W. Hinerman, Robert J. Amdur, Christopher G. Morris, & William M. Mendenhall. (2003). Radiation therapy for esthesioneuroblastoma: Rationale for elective neck irradiation. Head & Neck. 25(7). 529–534. 85 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026